サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1452712

心血管手術機器の世界市場、規模、シェア、予測（2024年～2032年）、産業動向、成長、考察 、主要企業の分析

Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry Trends, Growth, Insight, Top Companies Analysis
出版日: | 発行: Renub Research | ページ情報: 英文 200 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心血管手術機器の世界市場、規模、シェア、予測（2024年～2032年）、産業動向、成長、考察 、主要企業の分析
出版日: 2024年03月01日
発行: Renub Research
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心血管手術機器の市場規模は、2032年までに27億7,000万米ドルに達すると予測されています。近年、心血管外科機器は、患者の治療への大きな影響により、医療部門で脚光を浴びています。これらの機器は、低侵襲プロセスから精巧な外科手術に至るまで、多くの心血管疾患に対処するための近代的なソリューションを提供します。その精度、有効性、そして患者の回復期間を短縮する能力が、世界中の医療従事者の関心を集めています。さらに、技術の進歩により、これらの機器の保護と性能が向上し、現代の心血管医療においてトップクラスの結果を求める開業医と患者の両方にとって、ますます魅力的なものとなっています。

心血管手術機器の市場規模は、2024年～2032年にCAGRで3.46%の成長が見込まれます。

心臓病、糖尿病、生活習慣病の急増は、心臓手術機器市場の成長に大きく寄与しています。世界保健機関（WHO）によると、心血管疾患（CVD）は世界の死亡の主因であり、年間約1,790万人の命を奪っています。CVD関連死の5分の4超は心臓発作と脳卒中によるもので、3分の1は70歳未満で早期に発生しています。心臓病と脳卒中の主な行動リスクは、有害な栄養パターン、運動不足、タバコの消費、過度のアルコール摂取などです。

過去10年間にわたり、心臓機器技術とその警告サインの改善が心血管手術機器市場を推進してきました。改良された技術は、より高い患者の転帰、回復期間の短縮、高い満足度をもたらします。AIはそのような技術の1つで、先進のモニタリング能力を付与することで心臓病学を大幅に強化します。例えば、2023年、EkoはSENSORA（TM）Cardiac Disease Detection Platformを発売しました。このプラットフォームはAIを使用して構造的雑音を検出し、心臓弁膜症の診断を支援します。拡張されたツール指標は、多様な心血管の問題に対処する範囲を広げ、市場の成長と採用を促進します。したがって、心血管手術機器の市場規模は2023年に20億4,000万米ドルに達しました。

発展途上国市場における心血管手術機器に対する需要の高まりへの反応も、市場拡大に寄与しています。例えば、Abbottは2022年に現代技術の経カテーテル大動脈弁植込み（TAVI）機器、Navitorを発売し、インドで手術の危険性が高い大動脈弁狭窄症患者に対する低侵襲治療へのアクセスを増加させました。大動脈弁狭窄症は、一般的で重篤な冠動脈弁障害であり、兆候がほとんどないことがあります。しかし、National Institutes of Health（NIH）によれば、インドでは1,000人当たり4.54人がこの症状に苦しんでいます。

さらに、画期的な製品に対する規制当局からの承認の急増が、市場成長を広範囲にわたって後押ししています。また、製品の発売、承認、戦略的買収、改良は、心血管手術機器の市場参入企業が世界中でのプレゼンスを維持、拡大するために採用する重大な企業の手法です。例えば、2023年、AbbottとCardiovascular Systems, Inc.は、末梢疾患と動脈疾患に対処するために使用される革新的なアテレクトミーマシンで有名な医療機器企業であるCSIをAbbottが買収するための最終合意を開示しました。この買収によりAbbottは、CSIの補完的な技術により、主な血管機器のポートフォリオを増強する見込みです。

心血管手術機器市場では不整脈が重要な役割を果たします。

用途に基づき、心血管手術機器市場は先天性心疾患、不整脈、冠動脈疾患、うっ血性心不全、その他に分類されます。不整脈は、その有病率と生命を脅かす意味合いから、心血管手術機器市場において極めて重要です。このため、ペースメーカーやカテーテルアブレーション構造のような最新のソリューションの需要に拍車がかかっています。例えば、2024年にBoston Scientific CorporationがFARAPULSE（TM）Pulsed Field Ablation（PFA）SystemのFDA承認を取得し、薬剤不応性、再発性、症候性、発作性の心房細動を治療する独自の技術を提供しています。

当レポートでは、世界の心血管手術機器市場について調査し、市場力学、セグメント、地域、企業の包括的な分析を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長促進要因
  • 課題

第5章 心血管手術機器市場

第6章 市場シェア - 心血管手術機器市場

  • 製品タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第7章 製品タイプ - 心血管手術機器市場

  • 心拍動下手術システム
  • 人工心肺機器
  • 心臓アブレーション機器
  • 使い捨て灌流用品

第8章 用途 - 心血管手術機器市場

  • 先天性心疾患
  • 不整脈
  • 冠状動脈疾患
  • うっ血性心不全
  • その他

第9章 エンドユーザー - 心血管手術機器市場

  • 病院
  • 外来手術センター
  • その他

第10章 国 - 心血管手術機器市場

  • 北米
    • 米国
    • カナダ
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • 英国
    • ベルギー
    • オランダ
    • トルコ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • タイ
    • マレーシア
    • インドネシア
    • オーストラリア
    • ニュージーランド
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第11章 ポーターのファイブフォース分析 - 心臓手術機器市場

第12章 SWOT分析 - 心臓手術機器市場

第13章 主要企業の分析

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare
  • LivaNova PLC
  • Terumo Corporation
図表

List of Figures

  • Figure-01: Global - Cardiovascular Surgical Devices Market (Billion US$), 2019 - 2023
  • Figure-02: Global - Forecast for Cardiovascular Surgical Devices Market (Billion US$), 2024 - 2032
  • Figure-03: Product Type - Beating Heart Surgery Systems Market (Million US$), 2019 - 2023
  • Figure-04: Product Type - Forecast for Beating Heart Surgery Systems Market (Million US$), 2024 - 2032
  • Figure-05: Product Type - Cardiopulmonary Bypass Equipment Market (Million US$), 2019 - 2023
  • Figure-06: Product Type - Forecast for Cardiopulmonary Bypass Equipment Market (Million US$), 2024 - 2032
  • Figure-07: Product Type - Cardiac Ablation Devices Market (Million US$), 2019 - 2023
  • Figure-08: Product Type - Forecast for Cardiac Ablation Devices Market (Million US$), 2024 - 2032
  • Figure-09: Product Type - Perfusion Disposable Market (Million US$), 2019 - 2023
  • Figure-10: Product Type - Forecast for Perfusion Disposable Market (Million US$), 2024 - 2032
  • Figure-11: Application - Congential Heart Defects Market (Million US$), 2019 - 2023
  • Figure-12: Application - Forecast for Congential Heart Defects Market (Million US$), 2024 - 2032
  • Figure-13: Application - Cardiac Arrthymia Market (Million US$), 2019 - 2023
  • Figure-14: Application - Forecast for Cardiac Arrthymia Market (Million US$), 2024 - 2032
  • Figure-15: Application - Coronary Heart Disease Market (Million US$), 2019 - 2023
  • Figure-16: Application - Forecast for Coronary Heart Disease Market (Million US$), 2024 - 2032
  • Figure-17: Application - Congestive Heart Failure Market (Million US$), 2019 - 2023
  • Figure-18: Application - Forecast for Congestive Heart Failure Market (Million US$), 2024 - 2032
  • Figure-19: Application - Others Market (Million US$), 2019 - 2023
  • Figure-20: Application - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-21: End User - Hospitals Market (Million US$), 2019 - 2023
  • Figure-22: End User - Forecast for Hospitals Market (Million US$), 2024 - 2032
  • Figure-23: End User - Ambulatory Surgical Centers Market (Million US$), 2019 - 2023
  • Figure-24: End User - Forecast for Ambulatory Surgical Centers Market (Million US$), 2024 - 2032
  • Figure-25: End User - Others Market (Million US$), 2019 - 2023
  • Figure-26: End User - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-27: United States - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-28: United States - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-29: Canada - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-30: Canada - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-31: France - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-32: France - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-33: Germany - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-34: Germany - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-35: Italy - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-36: Italy - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-37: Spain - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-38: Spain - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-39: United Kingdom - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-40: United Kingdom - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-41: Belgium - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-42: Belgium - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-43: Netherland - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-44: Netherland - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-45: Turkey - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-46: Turkey - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-47: China - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-48: China - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-49: Japan - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-50: Japan - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-51: India - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-52: India - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-53: South Korea - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-54: South Korea - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-55: Thailand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-56: Thailand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-57: Malaysia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-58: Malaysia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-59: Indonesia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-60: Indonesia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-61: Australia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-62: Australia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-63: New Zealand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-64: New Zealand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-65: Brazil - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-66: Brazil - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-67: Mexico - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-68: Mexico - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-69: Argentina - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-70: Argentina - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-71: Saudi Arabia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-72: Saudi Arabia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-73: UAE - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-74: UAE - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-75: South Africa - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-76: South Africa - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-77: Abbott Laboratories - Global Revenue (Million US$), 2019 - 2023
  • Figure-78: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-79: Boston Scientific Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-80: Boston Scientific Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-81: Edwards Lifesciences - Global Revenue (Million US$), 2019 - 2023
  • Figure-82: Edwards Lifesciences - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-83: Cardinal Health Inc. - Global Revenue (Million US$), 2019 - 2023
  • Figure-84: Cardinal Health Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-85: Medtronic PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-86: Medtronic PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-87: GE Healthcare - Global Revenue (Million US$), 2019 - 2023
  • Figure-88: GE Healthcare - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-89: LivaNova PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-90: LivaNova PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-91: Terumo Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-92: Terumo Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032

List of Tables

  • Table-01: Global - Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2019 - 2023
  • Table-02: Global - Forecast for Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2024 - 2032
  • Table-03: Global - Cardiovascular Surgical Devices Market Share by Application (Percent), 2019 - 2023
  • Table-04: Global - Forecast for Cardiovascular Surgical Devices Market Share by Application (Percent), 2024 - 2032
  • Table-05: Global - Cardiovascular Surgical Devices Market Share by End User (Percent), 2019 - 2023
  • Table-06: Global - Forecast for Cardiovascular Surgical Devices Market Share by End User (Percent), 2024 - 2032
  • Table-07: Global - Cardiovascular Surgical Devices Market Share by Countries (Percent), 2019 - 2023
  • Table-08: Global - Forecast for Cardiovascular Surgical Devices Market Share by Countries (Percent), 2024 - 2032
目次

Cardiovascular Surgical Devices Market is predicted to reach US$ 2.77 Billion by 2032, according to Renub Research. Lately, cardiovascular surgical gadgets have received prominence inside the healthcare sector thanks to their large impact on affected person remedy. These devices give modern solutions for addressing numerous cardiovascular illnesses, spanning from minimally invasive processes to elaborate surgical procedures. Their precision, effectiveness, and ability to shorten affected person restoration durations have captured the interest of healthcare specialists globally. Moreover, technological progressions have improved the protection and performance of these devices, rendering them increasingly attractive to both practitioners and sufferers looking for top-rated consequences in contemporary cardiovascular healthcare.

Cardiovascular Surgical Devices Market is anticipated to increase at a CAGR of 3.46% from 2024 to 2032

The surge in cardiac illnesses, diabetes, and lifestyle disorders contributes considerably to the growth of the cardiac surgical devices market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the primary global reason of mortality, claiming approximately 17.9 million lives yearly. Over four-fifths of CVD-related deaths stem from heart attacks and strokes, with a third occurring prematurely in individuals under 70. Key behavioral risk elements for heart sickness and stroke encompass harmful nutritional patterns, a loss of physical activity, tobacco consumption, and excessive alcohol consumption.

Over the past decade, improvements in cardiac device technologies and their warning signs have propelled the cardiovascular surgical devices market. Improved technology yields higher patient outcomes, shorter recovery instances, and higher satisfaction rates. Artificial intelligence is one such technology that substantially enhances cardiology by imparting advanced monitoring abilities. For example, in 2023, Eko launched the SENSORA(TM) Cardiac Disease Detection Platform, which uses AI to detect structural murmurs, aiding in valvular heart disorder diagnosis. Expanded tool indicators widen their scope in addressing diverse cardiovascular issues, fostering market growth and adoption. Hence, the Cardiovascular Surgical Devices Market was worth US$ 2.04 Billion in 2023.

The reaction to heightened demands for cardiovascular surgical devices in developing nations also contributed to the market boom. For instance, in 2022, Abbott launched its contemporary-technology transcatheter aortic valve implantation (TAVI) device, Navitor, which increased access to minimally invasive remedies for intense aortic stenosis patients in India at excessive or intense surgical danger. Aortic stenosis, a general and severe coronary heart valve disorder, frequently lacks considerable signs. However, 4.54 per thousand individuals in India suffer from this condition, according to the National Institutes of Health (NIH).

Moreover, the surge in approvals from the regulatory authorities for groundbreaking products extensively drives the market's growth. Also, product launches, approvals, strategic acquisitions, and improvements are vital enterprise techniques employed by cardiovascular surgical devices market participants to maintain and expand their worldwide presence. For example, in 2023, Abbott and Cardiovascular Systems, Inc. disclosed a definitive agreement for Abbott to gather CSI, a medical device corporation famous for its revolutionary atherectomy machine used in addressing peripheral and artery disease. This acquisition will augment Abbott's leading vascular device portfolio with complementary technologies from CSI.

Cardiac arrhythmia plays a crucial role in the market for cardiovascular surgical devices

Based on Application, the Cardiovascular Surgical Devices Market is categorized into Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, and Others. Cardiac arrhythmia is pivotal in the cardiovascular surgical devices market because of its prevalence and life-threatening implications. This spurs demand for modern solutions like pacemakers and catheter ablation structures. For instance, in 2024, Boston Scientific Corporation received FDA approval for the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, offering a unique technique for treating drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

China significantly influences the market for cardiovascular surgical devices

The Cardiovascular Surgical Devices Market is split by country, including North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). China is important in the cardiovascular surgical devices market. This is due to its vast population, rising cardiovascular disorder rates, expanding healthcare infrastructure, increasing healthcare expenditure, and developing need for superior scientific technologies. For instance, in July 2022, China's National Medical Products Administration permitted an artificial coronary heart for excessive heart failure created by the China Academy of Launch Vehicle Technology and TEDA International Cardiovascular Hospital.

Key Players

The Cardiovascular Surgical Devices Market includes companies such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC, GE Healthcare, LivaNova PLC, and Terumo Corporation.

Product Type - Market breakup in 4 viewpoints:

1. Beating Heart Surgery Systems

2. Cardiopulmonary Bypass Equipment

3. Cardiac Ablation Devices

4. Perfusion Disposable

Application - Market breakup in 5 viewpoints:

1. Congenital Heart Defects

2. Cardiac Arrhythmia

3. Coronary Heart Disease

4. Congestive Heart Failure

5. Others

End-User - Market breakup in 3 viewpoints:

1. Hospitals

2. Ambulatory Surgical Centers

3. Others

Country - Market of 25 Countries Covered in the Report:

1. North America

  • 1.1 United States
  • 1.2 Canada

2. Europe

  • 2.1 France
  • 2.2 Germany
  • 2.3 Italy
  • 2.4 Spain
  • 2.5 United Kingdom
  • 2.6 Belgium
  • 2.7 Netherland
  • 2.8 Turkey

3. Asia Pacific

  • 3.1 China
  • 3.2 Japan
  • 3.3 India
  • 3.4 South Korea
  • 3.5 Thailand
  • 3.6 Malaysia
  • 3.7 Indonesia
  • 3.8 Australia
  • 3.9 New Zealand

4. Latin America

  • 4.1 Brazil
  • 4.2 Mexico
  • 4.3 Argentina

5. Middle East & Africa

  • 5.1 Saudi Arabia
  • 5.2 UAE
  • 5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue Analysis

Company Analysis:

1. Abbott Laboratories

2. Boston Scientific Corporation

3. Edwards Lifesciences

4. Cardinal Health Inc.

5. Medtronic PLC

6. GE Healthcare

7. LivaNova PLC

8. Terumo Corporation

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiovascular Surgical Devices Market

6. Market Share - Cardiovascular Surgical Devices Market

  • 6.1 By Product Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product Type - Cardiovascular Surgical Devices Market

  • 7.1 Beating Heart Surgery Systems
  • 7.2 Cardiopulmonary Bypass Equipment
  • 7.3 Cardiac Ablation Devices
  • 7.4 Perfusion Disposable

8. Application - Cardiovascular Surgical Devices Market

  • 8.1 Congential Heart Defects
  • 8.2 Cardiac Arrthymia
  • 8.3 Coronary Heart Disease
  • 8.4 Congestive Heart Failure
  • 8.5 Others

9. End User - Cardiovascular Surgical Devices Market

  • 9.1 Hospitals
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Others

10. Countries - Cardiovascular Surgical Devices Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherland
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Thailand
    • 10.3.6 Malaysia
    • 10.3.7 Indonesia
    • 10.3.8 Australia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 UAE
    • 10.5.3 South Africa

11. Porter's Five Forces Analysis - Cardiac Surgery Devices Market

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis - Cardiac Surgery Devices Market

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overview
    • 13.1.2 Recent Development
    • 13.1.3 Revenue Analysis
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Overview
    • 13.2.2 Recent Development
    • 13.2.3 Revenue Analysis
  • 13.3 Edwards Lifesciences
    • 13.3.1 Overview
    • 13.3.2 Recent Development
    • 13.3.3 Revenue Analysis
  • 13.4 Cardinal Health Inc.
    • 13.4.1 Overview
    • 13.4.2 Recent Development
    • 13.4.3 Revenue Analysis
  • 13.5 Medtronic PLC
    • 13.5.1 Overview
    • 13.5.2 Recent Development
    • 13.5.3 Revenue Analysis
  • 13.6 GE Healthcare
    • 13.6.1 Overview
    • 13.6.2 Recent Development
    • 13.6.3 Revenue Analysis
  • 13.7 LivaNova PLC
    • 13.7.1 Overview
    • 13.7.2 Recent Development
    • 13.7.3 Revenue Analysis
  • 13.8 Terumo Corporation
    • 13.8.1 Overview
    • 13.8.2 Recent Development
    • 13.8.3 Revenue Analysis